Asymmetric Therapeutics, LLC is a pioneering brand dedicated to advancing organ protection during systemic anti-cancer therapy. With a focus on mitigating the common side-effects of chemotherapy, such as nausea, diarrhea, and Hand-Foot Syndrome, Asymmetric Therapeutics has developed innovative and patented methods, compositions, and kits. Since its establishment in 2003, the brand has been at the forefront of medical advancements in cancer treatment.

Chemotherapy, while effective against a variety of cancers, often results in painful and detrimental side-effects that limit its clinical utility. Asymmetric Therapeutics aims to address this challenge by providing solutions that protect healthy tissues from the damaging effects of chemotherapeutic drugs. Their expertise has even led to the launch of two spin-off companies: Triaged Data Display (TDD) and Brain Fit Imaging.

These companies tackle different healthcare challenges by offering technologies like single-screen report visualization and cognitive function assessment based on magnetoencephalography. Discover the groundbreaking innovations of Asymmetric Therapeutics and their commitment to enhancing cancer treatments